MGM Healthcare builds world’s largest intestinal transplant program in 3 years
Since launching, the hospital has performed over 40 intestinal transplants, including 21 in 2025 alone
Since launching, the hospital has performed over 40 intestinal transplants, including 21 in 2025 alone
The programme aims to provide critical healthcare services to approximately 4 lakh people in remote and resource-scarce communities
This follows a $6 million expansion in Rosenberg in 2025 and signals a major push to boost commercial capacity, expand R&D capabilities, and meet rising demand for US-based drug product manufacturing
Both companies say the collaboration is driven by a shared mission to improve patient outcomes by aligning every step of the diagnostic process
The announcement marks Dr. Reddy’s Day?1 entry into the GLP?1 receptor agonists therapy space and readiness to serve patients in India
The move aims to accelerate drug discovery with AI-driven designs powered by NVIDIA technology
RSM01, a preventive treatment targeting respiratory syncytial virus (RSV), was licensed earlier this month from the Gates Medical Research Institute
The facility supports drug discovery, biomolecular research, and the development of next-generation diagnostics
The Taipei facility boasts 10 GMP API production lines, with a total reactor volume exceeding 350,000 liters
Subscribe To Our Newsletter & Stay Updated